|
SUVN-502: A safe, potent, selective, brain penetrant and orally active 5-HT6 receptor antagonist - first in human clinical phase-1 study |
|
|
|
Titel: |
SUVN-502: A safe, potent, selective, brain penetrant and orally active 5-HT6 receptor antagonist - first in human clinical phase-1 study |
Auteur: |
Nirogi, Ramakrishna Kambhampati, Ramasastri Shinde, Anil Kandikere, Vishwottam Mudigonda, Koteshwara Bhyrapuneni, Gopinadh Jayarajan, Pradeep Abraham, Renny Mulla, Mohmad Sadik Jasti, Venkat |
Verschenen in: |
Alzheimer's & dementia |
Paginering: |
Jaargang 5 (2009) nr. 4S pagina's P250 |
Jaar: |
2009 |
Inhoud: |
|
Uitgever: |
The Alzheimer's Association |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|